EPO and anemia (phenotype): Subsequently, chronic inflammation can lead to anemia through several pathways, e.g., induction of the master regulator of iron homeostasis hepcidin by Interleukin-6 or the inhibition of erythropoietin formation in the kidney mediated by Interleukin-1 and TNF-alpha (25).